5 Top Pipeline Stocks to Buy Now
An in-depth look at the best pipeline stocks.
Editors' Picks
Is ExxonMobil a Buy?
The oil giant has a long-term plan to enrich its investors.
Estee Lauder Hands in a Nearly Blemish-Free Earnings Report
The beauty giant closed out fiscal 2019 with palpable momentum while forecasting a vigorous year ahead.
Wearables Are Moving the Needle for Apple
As demand for the flagship iPhone continues to stagnate, other products and services are picking up the slack.
Recent articles
Why NVIDIA Stock Jumped 7% on Monday
Shares of the graphics-chip specialist got a boost from several catalysts, including the company's announcement of a big win in its gaming business.
Why Is Netflix Tracking Its Users' Physical Activity?
Here's one boring, likely answer and two speculative ones.
What is the Payroll Tax and How Much Does It Cost You?
Payroll taxes are taken out of your paycheck -- but what exactly are these taxes and how much are you paying for them?
2 Cannabis Stocks That Absolutely Crushed It in the Second Quarter
These marijuana stocks are delivering eye-opening growth, and they should be on your radar.
Is Apple iPhoning the Finance Industry?
A new credit card exclusive to Apple customers is getting a lot of hype.
Let's Face the Facts: Marijuana Stocks Grossly Overpaid for Their Acquisitions
The possibility of pot stocks writing down the value of their goodwill is growing.
Cummins's Guidance Raises Red Flags for Caterpillar
When peers warn about slowing end markets, it's usually a good idea to take heed.
Earnings Preview: Any Signs of Life at Nordstrom?
Shares of the fashion retail giant have fallen out of style over the past year, but investors may be underestimating Nordstrom's long-term earnings potential.
Sick of the Big 4 Wireless Carriers? There Are Alternatives
AT&T, Verizon, T-Mobile, and Sprint are not the only choices when picking a wireless plan. Is making the switch to prepaid the right option for you?
Deciphera Pharmaceuticals: Buy at the High?
Investors have run back to the stock after promising clinical results.
3 Stocks to Build Your Portfolio Around
Some stocks you merely buy. Others are at the core of your portfolio. These three belong in the latter category.
Before You Claim Social Security, Do a Savings Checkup
A simple assessment could lead you to the right filing decision.
Spotify Highlights Growth, Profitability, and Podcasts in Q2
The company still isn't making money, but it's making progress.
3 Stocks Anyone Can Understand
Netflix, Cintas, and Boston Beer are companies with businesses that are easy to grasp.
Warren Buffett's Portfolio Yields a Big Surprise
It's really about what Buffett didn't do in the second quarter that's so shocking.
Another Bullish Sign for Solar Stocks
Canadian Solar's earnings report showed some positive signs for the solar industry.
Forget the Inverted Yield Curve, These 3 Stocks Just Hit All-Time Highs
The charts for these three stocks show the kinds of curves that investors should really like -- trending upward.
AbbVie's Latest FDA Approval Is Its Most Important Immunology Win Since Humira
The FDA just gave a thumbs-up to rheumatoid arthritis drug Rinvoq. It could become AbbVie's biggest immunology blockbuster after Humira.
Canopy Growth Fired Him -- but Here's Why Bruce Linton Just Bought More Shares Anyway
Former Canopy Growth co-CEO Bruce Linton says that he's taking advantage of the stock's big sell-off to buy shares. Should investors follow his lead?
Why You Should Probably Avoid WeWork
WeWork insists it’s worth tech company hype and valuation but doesn’t back it up.